T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PMT
801
PennyMac Mortgage Investment
PMT
$828M
| $63.7M | 0.01% |
4,609,260
+460,177
| +11% | +$7.02M |
|
|
SAFE
802
DELISTED
Safehold Inc.
SAFE
| $63.6M | 0.01% |
1,797,511
+179,541
| +11% | +$7.81M |
|
803
Zurn Elkay Water Solutions
ZWS
$8.41B
| $63.5M | 0.01% |
2,332,742
-487,841
| -17% | -$14.8M |
|
804
Texas Pacific Land
TPL
$23.9B
| $63.4M | 0.01% |
383,409
+45
| +0% | +$7.36K |
|
805
Allogene Therapeutics
ALLO
$683M
| $63.4M | 0.01% |
5,559,176
+1,292,441
| +30% | +$11.5M |
|
806
Guardant Health
GH
$21.4B
| $63.4M | 0.01% |
1,570,742
+227,675
| +17% | +$11.3M |
|
807
Surgery Partners
SGRY
$1.99B
| $63.3M | 0.01% |
2,189,764
-472,157
| -18% | -$20.6M |
|
|
HTBK
808
DELISTED
Heritage Commerce
HTBK
| $63.2M | 0.01% |
5,912,961
+50,779
| +0.9% | +$568K |
|
|
HZNP
809
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $63.1M | 0.01% |
791,371
-24,740
| -3% | -$2.34M |
|
810
Ecolab
ECL
$77.4B
| $63M | 0.01% |
409,613
-38,537
| -9% | -$6.39M |
|
811
Nexstar Media Group
NXST
$5.81B
| $62.7M | 0.01% |
384,863
+16,222
| +4% | +$2.74M |
|
812
SPS Commerce
SPSC
$2.86B
| $62.1M | 0.01% |
549,739
+908
| +0.2% | +$103K |
|
813
Bumble
BMBL
$359M
| $62M | 0.01% |
2,201,721
+470,391
| +27% | +$12.8M |
|
814
Gentherm
THRM
$1.32B
| $61.9M | 0.01% |
991,137
+8,371
| +0.9% | +$564K |
|
|
CFB
815
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $61.5M | 0.01% |
4,661,637
+4,390
| +0.1% | +$59.1K |
|
816
Citizens Financial Group
CFG
$31.2B
| $61.4M | 0.01% |
1,721,121
+60,263
| +4% | +$2.38M |
|
817
Newmont
NEM
$120B
| $61.2M | 0.01% |
1,025,652
-111,041
| -10% | -$7.86M |
|
818
Payoneer
PAYO
$2.42B
| $61.2M | 0.01% |
15,601,619
+1,383,186
| +10% | +$6.17M |
|
819
Choice Hotels
CHH
$4.71B
| $60.8M | 0.01% |
544,632
+17,707
| +3% | +$2.3M |
|
820
United Rentals
URI
$69.7B
| $60.7M | 0.01% |
249,794
-14,065
| -5% | -$4.14M |
|
821
Churchill Downs
CHDN
$6.2B
| $60.7M | 0.01% |
633,352
-172,628
| -21% | -$17.2M |
|
822
Certara
CERT
$1.24B
| $60.6M | 0.01% |
2,825,525
-183,294
| -6% | -$3.62M |
|
823
10x Genomics
TXG
$7.58B
| $60.6M | 0.01% |
1,338,586
+187,833
| +16% | +$9.75M |
|
|
DFS
824
DELISTED
Discover Financial Services
DFS
| $60.2M | 0.01% |
636,743
-162,851
| -20% | -$17.4M |
|
825
Warner Bros
WBD
$69.6B
| $59.6M | 0.01% |
4,442,487
+4,200,272
| +1,734% | +$77.9M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.